PROS1 and neoplasm: Continued (androgen-dependent) PSA secretion and the presence in tumour samples of androgens and AR mRNA expression at levels associated with active AR signalling strongly suggest that reactivation of the AR and AR-responsive pathways is one mechanism by which tumours become resistant to androgen deprivation (Titus et al, 2005).